SEC Form PRE 14A filed by Amphastar Pharmaceuticals Inc.
$AMPH
Biotechnology: Pharmaceutical Preparations
Health Care
Unavailable
Unavailable
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 5/12/2025 | $30.00 | Overweight → Neutral | Analyst |
| 2/4/2025 | $66.00 → $36.00 | Overweight → Neutral | Piper Sandler |
| 11/22/2024 | $55.00 | Equal Weight | Wells Fargo |
| 3/5/2024 | $60.00 | Overweight | JP Morgan |
| 11/17/2023 | $63.00 | Neutral | BofA Securities |
| 7/25/2023 | $70.00 | Buy | Jefferies |
| 10/21/2022 | $36.00 | Buy | Jefferies |
| 7/29/2022 | $44.00 | Overweight | CapitalOne |